Stempeutics gets Japan process patent for its stem cell drug Stempeucel – Financial Express
|
Stempeutics gets Japan process patent for its stem cell drug Stempeucel
Financial Express Stempeutics Research, a group company of Manipal Education and Medical Group and a joint venture with Cipla Group, has been granted process patent from the Japan Patent Office (application no 2012-540529) for its novel stem–cell based drug … |
